At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,149 enrolled
Drug / intervention
ENDOMINDdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Evaluation Study of the CADe System ENDOMIND in Surveillance Endoscopy for Colorectal Cancer in German Outpatient Cohort
In Brief
A clinical study evaluating ENDOMIND for Surveillance Endoscopy for Colorectal Cancer and 3 related conditions. Completed, enrolled 1,149 participants across 1 site.
Detailed Summary
Evaluation of an artificial intelligence system for polyp detection (CADe)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurveillance Endoscopy for Colorectal Cancer, Artificial Intelligence, Polyps of Colon, CADe
CountriesGermany
CollaboratorsKlinikum Stuttgart
Timeline
N/ACompletedFinished
20222023202420252026
First PostedAug 2021
Enrollment StartSep 2021
Primary CompletionNov 2022
TodayJul 2026
First PostedAug 16, 2021
Enrollment StartSep 1, 2021
Primary CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.9 years ago
Interventions
ENDOMINDdevice
CADe system for Polyp detection